AU6742596A - Acylated oligopeptide derivatives having cell signal inhibiting activity - Google Patents

Acylated oligopeptide derivatives having cell signal inhibiting activity

Info

Publication number
AU6742596A
AU6742596A AU67425/96A AU6742596A AU6742596A AU 6742596 A AU6742596 A AU 6742596A AU 67425/96 A AU67425/96 A AU 67425/96A AU 6742596 A AU6742596 A AU 6742596A AU 6742596 A AU6742596 A AU 6742596A
Authority
AU
Australia
Prior art keywords
cell signal
inhibiting activity
signal inhibiting
oligopeptide derivatives
acylated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU67425/96A
Inventor
Giorgio Caravatti
Heinz Fretz
Pascal Furet
Carlos Garcia-Echeverria
Brigitte Gay
Joseph Rahuel
Joseph Schoepfer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG, Novartis AG filed Critical Ciba Geigy AG
Publication of AU6742596A publication Critical patent/AU6742596A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU67425/96A 1995-08-17 1996-08-06 Acylated oligopeptide derivatives having cell signal inhibiting activity Abandoned AU6742596A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9517060.1A GB9517060D0 (en) 1995-08-17 1995-08-17 Acylated oligopeptide derivatives
GB9517060 1995-08-17
PCT/EP1996/003473 WO1997008193A1 (en) 1995-08-17 1996-08-06 Acylated oligopeptide derivatives having cell signal inhibiting activity

Publications (1)

Publication Number Publication Date
AU6742596A true AU6742596A (en) 1997-03-19

Family

ID=10779519

Family Applications (1)

Application Number Title Priority Date Filing Date
AU67425/96A Abandoned AU6742596A (en) 1995-08-17 1996-08-06 Acylated oligopeptide derivatives having cell signal inhibiting activity

Country Status (6)

Country Link
EP (1) EP0846127A1 (en)
AU (1) AU6742596A (en)
CA (1) CA2227516A1 (en)
GB (1) GB9517060D0 (en)
WO (1) WO1997008193A1 (en)
ZA (1) ZA966967B (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9603227D0 (en) * 1996-02-15 1996-04-17 Pharmacia Spa Peptide antagonists of cellular mitogenesis and motogenesis and their therapeutic use
AU2807197A (en) * 1996-05-16 1997-12-05 Warner-Lambert Company Compounds inhibiting the association of the pdgf receptor and phosphatidylinositol 3-kinase and their use
US6307090B1 (en) 1999-01-22 2001-10-23 The United States Of America As Represented By The Department Of Health And Human Services Acylated oligopeptide derivatives having cell signal inhibiting activity
US7226991B1 (en) 1999-03-23 2007-06-05 United States Of America, Represented By The Secretary, Department Of Health And Human Services Phenylalanine derivatives
AU770920C (en) 1999-03-23 2004-10-07 Georgetown University Phenylalanine derivatives
US7125875B2 (en) 1999-04-15 2006-10-24 Bristol-Myers Squibb Company Cyclic protein tyrosine kinase inhibitors
US7871981B2 (en) 1999-10-22 2011-01-18 The United States Of America As Represented By The Department Of Health And Human Services Inhibition of cell motility, angiogenesis, and metastasis
WO2001028577A2 (en) * 1999-10-22 2001-04-26 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Inhibition of cell motility and angiogenesis by inhibitors of the grb2 sh2-domain
US7425537B2 (en) 2000-08-22 2008-09-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services SH2 domain binding inhibitors
WO2002016407A2 (en) * 2000-08-22 2002-02-28 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Sh2 domain binding inhibitors
WO2002036142A2 (en) * 2000-11-03 2002-05-10 University Of Vermont And State Agricultural College Compositions for inhibiting grb7
CN1523991A (en) 2001-08-10 2004-08-25 ��˹��ŵ�� Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia
GB0206215D0 (en) 2002-03-15 2002-05-01 Novartis Ag Organic compounds
US20050119163A1 (en) 2003-09-18 2005-06-02 The Government Of The United States Of America, As Represented By The Secretary, SH2 domain binding inhibitors
GB0512324D0 (en) 2005-06-16 2005-07-27 Novartis Ag Organic compounds
EP1812012A4 (en) * 2004-11-15 2010-02-17 Ceptyr Inc Protein tyrosine phosphatase inhibitors and methods of use thereof
US20120165310A1 (en) 2009-09-10 2012-06-28 Novartis Ag Ether derivatives of bicyclic heteroaryls
US20120289501A1 (en) 2009-11-25 2012-11-15 Novartis Ag Benzene-fused 6-membered oxygen-containing heterocyclic derivatives of bicyclic heteroaryls
EP2582680A1 (en) 2010-06-17 2013-04-24 Novartis AG Biphenyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivatives
EP2582681A1 (en) 2010-06-17 2013-04-24 Novartis AG Piperidinyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivatives
WO2012120469A1 (en) 2011-03-08 2012-09-13 Novartis Ag Fluorophenyl bicyclic heteroaryl compounds
EP3194572B1 (en) 2014-07-30 2023-10-25 Yeda Research and Development Co. Ltd. Media for culturing pluripotent stem cells
PL3464336T3 (en) * 2016-06-01 2022-05-16 Athira Pharma, Inc. Compounds
IT201600074606A1 (en) * 2016-07-18 2018-01-18 Italfarmaco Spa New benzo-N-hydroxy amide compounds having antitumor activity
US11602534B2 (en) 2017-12-21 2023-03-14 Hefei Institutes Of Physical Science, Chinese Academy Of Sciences Pyrimidine derivative kinase inhibitors
EP3914698A1 (en) 2019-01-23 2021-12-01 Yeda Research and Development Co. Ltd Culture media for pluripotent stem cells
US20220395553A1 (en) 2019-11-14 2022-12-15 Cohbar, Inc. Cxcr4 antagonist peptides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994007913A1 (en) * 1992-09-25 1994-04-14 Warner-Lambert Company Peptide antagonists of sh2 binding and therapeutic uses thereof
AU682906B2 (en) * 1993-10-25 1997-10-23 Parke, Davis & Company Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase
AU4972096A (en) * 1995-02-01 1996-08-21 Affymax Technologies N.V. Peptides and compounds that bind to sh2 domains

Also Published As

Publication number Publication date
WO1997008193A1 (en) 1997-03-06
CA2227516A1 (en) 1997-03-06
ZA966967B (en) 1997-02-17
EP0846127A1 (en) 1998-06-10
GB9517060D0 (en) 1995-10-25

Similar Documents

Publication Publication Date Title
AU6742596A (en) Acylated oligopeptide derivatives having cell signal inhibiting activity
AU4672196A (en) Voice activity detection
AU5533094A (en) Enzyme inhibitors
AU694635B2 (en) Arylsulfonyl hydroxamic acid derivatives
AU5224496A (en) Serving signals
AU6300696A (en) Rapamycin derivatives
AU5010896A (en) Activity recording device
AU6318196A (en) Novel benzimidazole derivatives having cgmp-phosphodisterase inhibiting activity
AU1195897A (en) Heteroarylcarboxamide derivatives
AU7053296A (en) Purin-6-one derivatives
AU7295196A (en) 4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity
AU7056796A (en) Antenna alarm detection system
AU4875296A (en) Isoxazolyl-benzoyl derivatives
AU7295096A (en) 4-phenyl-4-oxo-2-butenoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity
AU5763596A (en) 2-ureido-benzamide derivatives
AU5887196A (en) Prothrombin derivatives
AU6474496A (en) Amplifier for antennas
AU6191796A (en) Sulfonyl- or sulfinylbenzoylguanidine derivatives
PL327580A1 (en) Derivatives of thioles exhibiting metallopepsidase inhibiting activity
AUPN322995A0 (en) Hydrophone array
AU4862996A (en) Il-12 inhibition of b1 cell activity
AUPN710995A0 (en) Hydrophone and array thereof
AU6049796A (en) Lysyloxidase inhibitors
GB9505636D0 (en) Amplifying signals
AU4495996A (en) Dihydrophenazine derivatives